ArrowMark Colorado Holdings’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-740
Closed -$13K 371
2016
Q3
$13K Buy
+740
New +$13.7K ﹤0.01% 329

Other funds holding IRMD

ArrowMark Colorado Holdings's IRMD Position: Q4 2016 in Review

ArrowMark Colorado Holdings sold out of iRadimed (IRMD) in Q4 2016, closing a stake of 740 shares — an estimated $13K sold.

ArrowMark Colorado Holdings first reported a position in IRMD in Q3 2016 and held it in 1 quarter. The position peaked at $13K in Q3 2016. 58 funds tracked by Wall St. Rank hold IRMD as of Q4 2016.

  • ArrowMark Colorado Holdings reported no remaining iRadimed position as of Q4 2016 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 740 iRadimed shares in Q4 2016, an estimated $13K.
  • ArrowMark Colorado Holdings first reported a position in iRadimed in Q3 2016 and held it in 1 quarter.
  • ArrowMark Colorado Holdings's iRadimed position peaked at $13K in Q3 2016.
  • 58 funds tracked by Wall St. Rank held iRadimed as of Q4 2016.

Based on ArrowMark Colorado Holdings's 13F filing for Q4 2016, filed 14 Feb 2017.